Mineralys Therapeutics, Inc. Common Stock Dividends
The next dividend date for Mineralys Therapeutics, Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Mineralys Therapeutics, Inc. Common Stock (MLYS)
More About Mineralys Therapeutics, Inc. Common Stock
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company's clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. It has initiated a Phase 2 trial for lorundrostat in hypertensive patients with stage 2 to 3b chronic kidney disease and a pivotal clinical program of lorundrostat for the treatment of uncontrolled or resistant hypertension. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Owning Mineralys Therapeutics, Inc. Common Stock Stock on the Dividend Date
If you own Mineralys Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Mineralys Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Mineralys Therapeutics, Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Mineralys Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Mineralys Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Mineralys Therapeutics, Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Mineralys Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.